Who
Andrew Arno
Director
Company insider
Files Form 4 as: Director, Insight Molecular Diagnostics; Director, Catheter Precision; Director, Smith Micro Software; Director, 22nd Century Group; Director, Asterias Biotherapeutics.
In numbers
- Trades disclosed
- 87
- Buys
- 15
- Sells
- 0
- Bought
- $705K
- Sold
- $0
- Companies
- 5
- Companies where not an officer
- 5
- First trade
- 27 Jul 2011
- Last trade
- 1 Jul 2026
- Last filed
- 6 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month. 2 lines have no legible date and are left out.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jul 2026filed 6 Jul 2026 | IMDX Insight Molecular DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $69K12,100 at $5.69 | filing |
| 1 Jul 2026filed 6 Jul 2026 | IMDX Insight Molecular DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $69K12,100 at $5.69 | filing |
| 11 Jun 2026filed 15 Jun 2026 | IMDX Insight Molecular DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —32,331 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | IMDX Insight Molecular DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —32,331 at $0.00 | filing |
| 26 Mar 2026filed 30 Mar 2026 | Catheter Precisionoption or derivative · Medical Devices | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 26 Mar 2026filed 30 Mar 2026 | Catheter Precisionoption or derivative · Medical Devices | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 9 Mar 2026filed 10 Mar 2026 | SMSI Smith Micro SoftwareSoftware | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 9 Mar 2026filed 10 Mar 2026 | SMSI Smith Micro SoftwareSoftware | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 10 Nov 2025filed 14 Nov 2025 | XXII 22nd Century Groupoption or derivative · Tobacco & Nicotine | SEC FORM 4 Code A | —51,888 at $0.00 | filing |
| 10 Nov 2025filed 14 Nov 2025 | XXII 22nd Century GroupTobacco & Nicotine | SEC FORM 4 Code A | —17,295 at $0.00 | filing |
| 9 Oct 2025filed 29 Oct 2025 | SMSI Smith Micro SoftwareSoftware | SEC FORM 4 Code A | —7,993 at $0.00 | filing |
| 12 Aug 2025filed 14 Aug 2025 | Catheter Precisionoption or derivative · Medical Devices | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 1 Jul 2025filed 3 Jul 2025 | IMDX Insight Molecular DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —55,000 at $0.00 | filing |
| 10 Mar 2025filed 12 Mar 2025 | XXII 22nd Century Groupoption or derivative · Tobacco & Nicotine | SEC FORM 4 Code A | —12,713 at $0.00 | filing |
| 10 Mar 2025filed 12 Mar 2025 | XXII 22nd Century GroupTobacco & Nicotine | SEC FORM 4 Code A | —4,237 at $0.00 | filing |
| 29 Jan 2025filed 31 Jan 2025 | Catheter Precisionoption or derivative · Medical Devices | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 23 Jan 2025filed 27 Jan 2025 | SMSI Smith Micro SoftwareSoftware | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 26 Dec 2024filed 26 Dec 2024 | IMDX Insight Molecular DiagnosticsDiagnostics & Labs | SEC FORM 4 Bought | $26K12,500 at $2.11 | filing |
| 1 Jul 2024filed 3 Jul 2024 | IMDX Insight Molecular Diagnosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 20 May 2024filed 22 May 2024 | IMDX Insight Molecular Diagnosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
News
CS Disco (NYSE:LAW) vs. Smith Micro Software (NASDAQ:SMSI) Head to Head ComparisonSMSI · tickerreport.com · 18 Oct 202622nd Century Same Store Unit Sales for Pinnacle VLN® and Pinnacle Pure Surge 161%XXII · manilatimes.net · 15 Oct 2026Oncocyte (NASDAQ:IMDX) and Alnylam Pharmaceuticals (NASDAQ:ALNY) Critical SurveyIMDX · tickerreport.com · 14 Oct 2026Head to Head Analysis: Smith Micro Software (NASDAQ:SMSI) versus zSpace (NASDAQ:ZSPC)SMSI · dailypolitical.com · 13 Oct 2026Reviewing Aktis Oncology (NASDAQ:AKTS) and Oncocyte (NASDAQ:IMDX)IMDX · tickerreport.com · 7 Oct 2026
0 headlines in the last 90 days name Andrew Arno; 5 articles from the last 14 days about the 3 companies they traded most, at most three about any one of them.